Key facts
- This page summarizes INTERWEST PARTNERS X LP's Form 4 filing for PMV Pharmaceuticals, Inc. (PMVP).
- 6 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 14 Jul 2021, 20:05.
INTERWEST PARTNERS X LP - 13 Jul 2021 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- PMVP
- Reported as of
- 13 Jul 2021
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 14 Jul 2021, 20:05:31 UTC
- Prior SEC filing
- 28 Jun 2021
- Next SEC filing
- 15 Nov 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Karen A. Wilson, Attorney-in Fact for InterWest Partners X, LP
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
INTERWEST PARTNERS X LP filed Form 4 for PMV Pharmaceuticals, Inc. (PMVP) on 14 Jul 2021.
Change
- Previous filing in this sequence was filed on 28 Jun 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PMVP
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- -500,000
- Change %
- -10%
- Price
- $0.000000
- Shares after
- 4,469,911
- Date
- 13 Jul 2021
- Ownership
- Direct
- Footnotes
- F1
PMVP
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- +97,632
- Change %
- Price
- $0.000000
- Shares after
- 97,632
- Date
- 13 Jul 2021
- Ownership
- By: InterWest Management Partners X, LLC
- Footnotes
- F1, F3
PMVP
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- -97,632
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 13 Jul 2021
- Ownership
- By: InterWest Management Partners X, LLC
- Footnotes
- F2, F3
PMVP
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- +3,642
- Change %
- +652%
- Price
- $0.000000
- Shares after
- 4,201
- Date
- 13 Jul 2021
- Ownership
- By: Khaled A. Nasr
- Footnotes
- F2, F3
PMVP
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- +2,441
- Change %
- +651%
- Price
- $0.000000
- Shares after
- 2,816
- Date
- 13 Jul 2021
- Ownership
- By: Keval Desai
- Footnotes
- F2, F3
PMVP
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- +22,148
- Change %
- +651%
- Price
- $0.000000
- Shares after
- 25,552
- Date
- 13 Jul 2021
- Ownership
- By Gilbert H. Kliman
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
INTERWEST PARTNERS X LP is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 3 footnotes
Footnote F1
Represents pro rata in-kind distribution by InterWest Partners X, LP ("IW10") without consideration to its limited and general partners in accordance with the terms of the InterWest Partners X, LP Limited Partnership Agreement. Includes 97,632 shares distributed to InterWest Management Partners X, LLC ("IMP10") its general partner.
Footnote F2
Represents pro rata in-kind distribution by IMP10 without consideration to its members in accordance with the terms of the InterWest Management Partners X, LLC Operating Agreement. Includes 3,642 shares distributed to Khaled A. Nasr ("Nasr"), 2,441 shares distributed to Keval Desai ("Desai") and 22,148 shares distributed to Gilbert H. Kliman ("Kliman").
Footnote F3
The shares are held directly by IW10. The general partner of IW10 is IMP10. Kliman is a Managing Director of IMP10 and Nasr and Desai are Venture Members of IMP10. Each of Nasr, Desai and Kliman share voting and investment control over the shares owned by IW10, and may be deemed to beneficially own the shares held by IW10. Each of Nasr, Desai and Kliman disclaims beneficial ownership of such shares except to the extent of his pecuniaryinterest theriein.